Bülent Erdoğan

5PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

|Jan 28, 2026
Integration of the GRIm Score with Pathologic Immune and Stromal Markers to Develop a Combined Prognostic Model in Gastric Cancer: A Retrospective Single-Center Study.

Gökhan Öztürk, Ebru Taştekin, Canberk Topuz

|Jul 07, 2025
Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2- Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups.

Erkan Ozcan, Ivo Gokmen, Fahri Akgul

|Feb 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization.

Muhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen

|Oct 27, 2023
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer.

İvo Gökmen, Ebru Taştekin, Nazan Demir

Pageof 1

Frequent Collaborators

3 joint publications

İvo Gökmen

3 joint publications

Muhammet Bekir Hacıoğlu

2 joint publications

Ebru Taştekin

2 joint publications

Erkan Özcan